輸入代號或公司名稱後按 Enter
MRVI

MARAVAI LIFESCIENCES HOLDINGS, INC.

+0.55 (+8.04%)前一交易日收盤 2026-09-17
美股 · Nasdaq · 生技醫療 · Pharmaceutical Preparations
7.39USD1.0M成交股數1.1B市值本益比(近四季)5.2股價營收比+8.5%營收年增(近四季)2026-11-05下次財報

財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束

逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。

營收與利潤率近 16 季

稀釋 EPS近 16 季 · 美元

現金流近 16 季

股東回饋近 16 季 · 庫藏股與股利

損益表 逐季 · 最新在左 · 小字是年增率

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
營收51.4M+10%65.8M+16%41.6M-40%47.4M-32%46.9M-27%56.6M-15%69.0M+0%69.4M-12%64.2M66.9M68.9M79.0M
營業成本30.8M32.1M36.0M39.6M39.1M37.2M36.8M38.6M38.3M36.7M43.3M33.7M
毛利20.7M+167%33.7M+74%5.7M-82%7.8M-75%7.7M-70%19.4M-36%32.2M+26%30.8M-32%25.8M30.2M25.6M45.3M
毛利率40.1%51.2%13.6%16.4%16.5%34.3%46.7%44.4%40.3%45.1%37.2%57.4%
研發費用3.7M3.9M3.8M4.9M4.9M4.6M4.7M4.9M5.0M4.3M4.2M4.1M
銷售管理費用32.1M29.1M35.4M38.7M39.6M41.2M39.1M40.6M40.9M38.9M35.4M38.7M
營業利益−15.1M-69%−2.2M-94%−41.0M-75%−66.3M+393%−49.2M+161%−37.7M+145%−166M+1326%−13.4M-631%−18.9M−15.4M−11.6M2.5M
營業利益率-29.3%-3.3%-98.6%-139.8%-104.9%-66.7%-239.9%-19.4%-29.4%-23.1%-16.9%3.2%
稅後淨利−12.4M-59%−3.7M-86%−25.6M-74%−39.6M+304%−29.9M+148%−25.9M+300%−97.1M+1384%−9.8M+14510%−12.1M−6.5M−6.5M−67K
淨利率-24.1%-5.7%-61.4%-83.5%-63.9%-45.7%-140.6%-14.1%-18.8%-9.7%-9.5%-0.1%
稀釋 EPS-0.08-62%-0.02-90%-0.18-74%-0.27+286%-0.21+133%-0.21+320%-0.68+1260%-0.07-0.09-0.05-0.050.00
稀釋股數148M146M145M144M143M138M142M136M132M132M132M132M

資產負債表 期末餘額

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
現金與約當現金70.1M166M244M270M285M322M578M573M562M580M580M628M
應收帳款31.1M33.4M22.5M27.9M28.5M38.5M28.8M34.7M36.7M45.7M49.0M56.3M
存貨41.2M40.5M45.3M46.7M49.8M50.1M50.5M49.3M49.8M49.1M47.4M54.8M
總資產604M713M849M897M960M1.0B1.3B1.4B1.4B2.3B2.3B2.3B
有息負債146M236M287M288M289M290M516M517M518M520M520M521M
總負債248M344M417M429M429M431M666M671M667M1.4B1.4B1.4B
股東權益205M212M245M266M301M325M345M435M411M519M521M522M
負債比41.1%48.3%49.1%47.8%44.7%42.8%52.1%46.5%46.2%60.7%60.4%61.1%
淨現金(現金 − 有息負債)−75.9M−69.6M−43.8M−18.5M−4.4M31.9M61.9M56.1M43.8M60.1M59.8M107M

現金流量表 單季

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
營業現金流8.7M−9.4M+11%−8.5M85.1M
資本支出4.4M4.5M5.7M7.9M
自由現金流4.2M−13.9M-2%−14.1M77.2M
折舊攤銷
買回庫藏股
現金股利
自由現金流率6.4%-29.6%-22.0%97.7%

營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度

業務分部2025 年度 · 186M
Tri Link120M64.5%-39.0%
Cygnus66.0M35.5%+5.0%
地區2025 年度 · 184M
美國111M60.2%-10.3%
亞太41.5M22.5%-53.6%
歐洲中東非洲30.9M16.8%-26.5%
Latin And Central America971K0.5%+46.7%
North America 小計112M61.0%-11.6%

各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。

年度 10-K

財年營收年增稅後淨利淨利率稀釋 EPS自由現金流
FY2025186M-28.3%−131M-70.4%-0.90−70.7M
FY2024259M-10.3%−145M-55.9%-1.05−22.2M
FY2023289M-67.3%−138M-47.9%-0.9060.7M
FY2022883M+10.5%491M55.6%1.67519M
FY2021799M+181.3%469M58.7%1.56354M
FY2020284M89.0M31.3%2.36127M
FY202088.2M%
FY2019143M−4.5M-3.1%-0.037.0M